Search results
Merck (MRK) Keytruda Ok'd by FDA for Expanded Cervical Cancer Use
Zacks via Yahoo Finance· 4 months agoFDA approves Merck's (MRK) Keytruda plus chemoradiotherapy (CRT) for patients with FIGO 2014 Stage...
Merck's (MRK) Keytruda-Lynparza Combo Fails 2nd Lung Cancer Study
Zacks via Yahoo Finance· 2 months agoMerck's attempt to use the Keytruda-Lynparza combination in certain non-small cell lung cancer...
Merck (MRK) Gets CHMP Nod for Keytruda in Adjuvant Lung Cancer
Zacks via Yahoo Finance· 8 months agoMerck's (MRK) Keytruda gets a positive CHMP opinion, recommending the approval of the drug for the...
Merck keeps deal focus with Keytruda patent cliff on horizon
BioPharma Dive via Yahoo Finance· 3 months agoMerck & Co. plans to continue seeking out multibillion-dollar biotechnology deals to supplement its...
Merck's (MRK) Keytruda for Liver Cancer to Undergo FDA Review
Zacks via Yahoo Finance· 11 months agoFDA accepts Merck's (MRK) supplemental biologics license application for Keytruda plus chemotherapy...
Patients seek relief from spiraling drug prices. Will the Inflation Reduction Act deliver?
USA TODAY via Yahoo News· 2 years agoJackie Trapp has incurable blood cancer and takes a chemotherapy drug that cost more than $240,000...
Merck Scores Major Drug Approval, Easing Pain From Keytruda Patent Expiration
Barrons.com· 1 month agoMerck secured Food and Drug Administration approval for a drug widely expected to be an era-defining...
Merck (MRK) Keytruda Advanced Gastric Cancer Study Meets Goal
Zacks via Yahoo Finance· 1 year agoTop-line data from a late-stage study shows that Merck's (MRK) Keytruda combined with chemotherapy...
Column: Merck says it's being 'coerced' into negotiating its drug prices with Medicare. That's...
LA Times via Yahoo Finance· 11 months agoThe big drugmaker Merck wants to stifle Medicare's right to negotiate drug prices. (Mel Evans /...
Merck Reports Progress On The Cancer Front As It Prepares For Keytruda Patent Expiration
Benzinga via Yahoo Finance· 1 week agoAfter topping expectations with first quarter revenue and adjusted earnings last week, Merck & Co...